Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Oct;8(5):681-685.
doi: 10.1002/jcsm.12245.

Recent developments in Duchenne muscular dystrophy: facts and numbers

Maggie C Walter  1 , Peter Reilich  1
Affiliations
Editorial

Recent developments in Duchenne muscular dystrophy: facts and numbers

Maggie C Walter et al. J Cachexia Sarcopenia Muscle. 2017 Oct.
No abstract available

PubMed Disclaimer

References

    1. Thompson R, Straub V. Limb‐girdle muscular dystrophies—international collaborations for translational research. Nat Rev Neurol 2016;12:294–309. - PubMed
    1. Seto JT, Bengtsson NE, Chamberlain JS. Therapy of genetic disorders‐novel therapies for Duchenne muscular dystrophy. Curr Pediatr Rep 2014;2:102–112. - PMC - PubMed
    1. Guiraud S, Aartsma‐Rus A, Vieira NM, Davies KE, van Ommen GJ, Kunkel LM. The pathogenesis and therapy of muscular dystrophies. Annu Rev Genomics Hum Genet 2015;16:281–308. - PubMed
    1. Gee P, Xu H, Hotta A. Cellular reprogramming, genome editing, and alternative CRISPR Cas9 technologies for precise gene therapy of Duchenne muscular dystrophy. Stem Cells Int 2017;2017: 8765154. - PMC - PubMed
    1. Mendell JR, Lloyd‐Puryear M. Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy. Muscle Nerve 2013;48:21–26. - PubMed

Publication types

MeSH terms